Zurich Cantonal Bank
SIOX

Zurich Cantonal Bank’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Zurich Cantonal Bank’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-414
Closed -$4K – 2549
2018
Q1 		$4K Hold
414
– – ﹤0.01% 2531
2017
Q4 		$17K Hold
414
– – ﹤0.01% 2444
2017
Q3 		$23K Hold
414
– – ﹤0.01% 2219
2017
Q2 		$77K Buy
414
+90
+28% +$15.8K ﹤0.01% 1517
2017
Q1 		$39K Hold
324
– – ﹤0.01% 1933
2016
Q4 		$32K Buy
+324
New +$34.1K ﹤0.01% 2038

Other funds holding SIOX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Zurich Cantonal Bank's SIOX Position: Q2 2018 in Review

Zurich Cantonal Bank sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q2 2018, closing a stake of 414 shares — an estimated $4K sold.

Zurich Cantonal Bank first reported a position in SIOX in Q4 2016 and held it in 6 quarters. The position peaked at $77K in Q2 2017. 71 funds tracked by Wall St. Rank hold SIOX as of Q2 2018.

  • Zurich Cantonal Bank reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • Zurich Cantonal Bank sold 414 Sio Gene Therapies Inc. Common Stock shares in Q2 2018, an estimated $4K.
  • Zurich Cantonal Bank first reported a position in Sio Gene Therapies Inc. Common Stock in Q4 2016 and held it in 6 quarters.
  • Zurich Cantonal Bank's Sio Gene Therapies Inc. Common Stock position peaked at $77K in Q2 2017.
  • 71 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q2 2018.

Based on Zurich Cantonal Bank's 13F filing for Q2 2018, filed 6 Aug 2018.